Page 7 - Term Liabilities News Today

Investegate announcements from Minerva Neurosciences, Inc, Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business Updates

Company to Host Conference Call Today at 8:30 a.m. ETBURLINGTON, Mass., March 08, 2023(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central

DALTON, GA / ACCESSWIRE / March 2, 2023 / The Dixie Group, Inc. (NASDAQ:DXYN) today reported financial results for the fiscal year ended December 31, 2022.Net sales for the fiscal year of 2022 were $304

This amount excludes $12,139 thousand of unamortized debt discount as of December 31, 2022. See Note 9-Notes Payable for details. - The amount excludes $437 thousand of unamortized debt discount as... | March 1, 2023

Finished 2022 ahead of guidance, with total revenue of $355.0 million in the fourth quarter, up 6% y/y; total revenue was $361.4 million and up 8% y/y on a...

FOUNTAIN VALLEY, Calif.--(BUSINESS WIRE)--Feb 14, 2023--

Total MRI scan volume at the HMCA-managed sites decreased 5% to 89,888 scans for the six months ending December 31, 2022 versus the corresponding period one year earlier. Cash and cash equivalents and

TEL AVIV & NEW YORK--(BUSINESS WIRE)--Perion Network Ltd. (NASDAQ & TASE: PERI), a global advertising technology company whose synergistic solutions are delivered across the three primary channels

Results of Operations for the Fiscal Years Ended October 31, 2022 and 2021 The following table shows the results of our operations and the percentage of revenues, cost of goods sold, gross profit,... | January 21, 2023

/PRNewswire/ -- ClearSign Technologies Corporation (Nasdaq: CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion and sensing...